BioGaia said that apart from positive results on gastrointestinal symptoms and hospital stay, supplementation of L reuteri protectis also led to a reduction in number of days of
Eisai Limited is working with Health Canada on the approval of select products from the Eisai portfolio to be introduced in the Canadian market. Eisai said that in
For the first quarter of 2010, Watson Pharmaceuticals posted a net income of $69.8m, or $0.57 per diluted share, compared to $49.1m, or $0.43 per diluted share, for
Generex is expected to continue to monitor and execute the ongoing Generex Oral-lyn study according to protocol and national/international ICH-GCPs. The study’s endpoint is for Generex Oral-lyn to
In this newly created role, Mr Berger will be responsible for developing Catalent’s global marketing strategy, implementing marketing excellence across all business units as well as building Catalent’s
Mr Gemignani brings to Coronado 25 years of accounting, planning and finance experience that includes employment at a broad spectrum of life science businesses including emerging biotech, big
GenScript said that antibody drug is among the powerful forms of medication. There are research and development activities to develop antibody drugs for numerous serious diseases, such as
Cleveland BioLabs said that CBLB502 is being developed under the FDA’s Animal Efficacy Rule to treat ARS or radiation poisoning from any exposure to radiation such as a
Dr Novak will be responsible for Fate’s drug discovery and development activities focused on advancing its pipeline of stem cell modulators, small molecules or biologics that guide cell
Valeant Onsolis is an opioid analgesic indicated only for the management of breakthrough pain in cancer patients, 18 years of age and older, who are already receiving and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.